20th AMN Congress

The Academy of Multidisciplinary Neurotraumatology (AMN) invites to the annual congress in the beautiful city of Krakow in Poland from 12 - 13 May 2023. A new record number of delegates is expected.

Unique interaction of medical disciplines

The vision of the AMN is that all patients suffering from a traumatic brain injury receive the best possible care. The widely accepted concept of multidisciplinary treatment means that different medical specialties involved in the recovery chain of a TBI discuss optimal treatment standards and work closely together and – very important – communicate with each other.

Unique congress format

The formation of multidisciplinary teams requires interaction between different medical professionals instead of isolated medical decision-making. The AMN congress supports this idea and consequently develops its congress programs as interactively as possible. In addition to the traditional frontal lectures, the delegates can look forward to highly relevant teaching courses, panel discussions and interviews.

EVER Pharma at AMN

Traumatic Brain Injury is a serious medical burden in most low- and middle-income countries. EVER Pharma is particularly active in countries and regions of the world where the burden is very high. EVER Pharma is also one of the few companies that is actively involved in clinical TBI research and has been able to achieve real breakthroughs in the development of clinical evidence with the CAPTAIN publication series.

EVER Pharma is looking forward to participating in the AMN Congress. We’ll meet there!